Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Han

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Endocrinology and Metabolism (Seoul, Korea)|October 4, 2022
Association between the Diabetes Drug Cost and Cardiovascular Events and Death in Korea: A National Health Insurance Service Database AnalysisSeung Min Chung, Ji-In Lee, Eugene Han, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2018
Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in KoreaEugene Han, Ari Kim, Sung Jae Lee, et al.
Cardiovascular Diabetology|July 15, 2025
Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortalityEugene Han, Kyung-Do Han, Yong-Ho Lee, et al.
International Journal of Molecular Sciences|October 14, 2022
Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver CellsHye-Young Seo, So-Hee Lee, Eugene Han, et al.
Medicine|September 3, 2020
Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetesEugene Han, Yongin Cho, Kyung-Won Kim, et al.
International Journal of Cancer|November 19, 2016
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control studyGyuri Kim, Suk-Yong Jang, Eugene Han, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 11, 2020
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes MellitusEugene Han, Minyoung Lee, Yong-Ho Lee, et al.
Medicine|February 13, 2016
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 DiabetesEugene Han, Suk-Yong Jang, Gyuri Kim, et al.
Diabetes & Metabolism Journal|March 28, 2023
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017Eugene Han, Kyung-Do Han, Yong-Ho Lee, et al.
Diabetes Research and Clinical Practice|April 30, 2025
Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular diseaseEugene Han, Sin Yung Woo, Justin Y Jeon, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Endocrinology and Metabolism (Seoul, Korea)|October 4, 2022
Association between the Diabetes Drug Cost and Cardiovascular Events and Death in Korea: A National Health Insurance Service Database AnalysisSeung Min Chung, Ji-In Lee, Eugene Han, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 13, 2018
Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in KoreaEugene Han, Ari Kim, Sung Jae Lee, et al.
Cardiovascular Diabetology|July 15, 2025
Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortalityEugene Han, Kyung-Do Han, Yong-Ho Lee, et al.
International Journal of Molecular Sciences|October 14, 2022
Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver CellsHye-Young Seo, So-Hee Lee, Eugene Han, et al.
Medicine|September 3, 2020
Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetesEugene Han, Yongin Cho, Kyung-Won Kim, et al.
International Journal of Cancer|November 19, 2016
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control studyGyuri Kim, Suk-Yong Jang, Eugene Han, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 11, 2020
Effect of Switching from Linagliptin to Teneligliptin Dipeptidyl Peptidase-4 Inhibitors in Older Patients with Type 2 Diabetes MellitusEugene Han, Minyoung Lee, Yong-Ho Lee, et al.
Medicine|February 13, 2016
Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 DiabetesEugene Han, Suk-Yong Jang, Gyuri Kim, et al.
Diabetes & Metabolism Journal|March 28, 2023
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017Eugene Han, Kyung-Do Han, Yong-Ho Lee, et al.
Diabetes Research and Clinical Practice|April 30, 2025
Impact of physical activities in metabolic dysfunction associated steatotic liver disease, sarcopenia, and cardiovascular diseaseEugene Han, Sin Yung Woo, Justin Y Jeon, et al.
Pageof 8